| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The case for early detection.
|
Nat Rev Cancer
|
2003
|
6.96
|
|
2
|
Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
|
Arch Intern Med
|
2010
|
2.04
|
|
3
|
Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
|
J Clin Oncol
|
2010
|
1.84
|
|
4
|
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
J Clin Oncol
|
2008
|
1.69
|
|
5
|
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
|
Genet Med
|
2012
|
1.39
|
|
6
|
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
|
J Clin Oncol
|
2007
|
1.28
|
|
7
|
A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.
|
Value Health
|
2011
|
1.24
|
|
8
|
Cancer biomarkers: a systems approach.
|
Nat Biotechnol
|
2006
|
1.23
|
|
9
|
Evaluation of a cervical cancer control intervention using lay health workers for Vietnamese American women.
|
Am J Public Health
|
2010
|
1.20
|
|
10
|
Prioritization in comparative effectiveness research: the CANCERGEN Experience.
|
Med Care
|
2012
|
1.17
|
|
11
|
The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.
|
J Urol
|
2005
|
1.16
|
|
12
|
Examining the cost-effectiveness of cancer screening promotion.
|
Cancer
|
2004
|
1.07
|
|
13
|
AACR Cancer Progress Report 2014.
|
Clin Cancer Res
|
2014
|
1.05
|
|
14
|
Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.01
|
|
15
|
Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery.
|
J Thorac Cardiovasc Surg
|
2004
|
1.00
|
|
16
|
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
|
Head Neck
|
2012
|
0.96
|
|
17
|
Adverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer.
|
Clin Colorectal Cancer
|
2012
|
0.86
|
|
18
|
Assessing the equality of means of healthcare costs.
|
Expert Rev Pharmacoecon Outcomes Res
|
2003
|
0.84
|
|
19
|
Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.
|
J Comp Eff Res
|
2012
|
0.83
|
|
20
|
The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.
|
Health Econ
|
2009
|
0.82
|
|
21
|
Patterns of skeletal trauma in suicidal bridge jumpers: a retrospective study from the southeastern United States.
|
Forensic Sci Int
|
2013
|
0.81
|
|
22
|
Breast cancer multigene testing trends and impact on chemotherapy use.
|
Am J Manag Care
|
2016
|
0.81
|
|
23
|
Paying for personalized care: cancer biomarkers and comparative effectiveness.
|
Mol Oncol
|
2012
|
0.80
|
|
24
|
Localized prostate cancer: quality of life meets Whitmore's legacy.
|
J Natl Cancer Inst
|
2004
|
0.79
|
|
25
|
Medical costs associated with use of systemic therapy in adults with colorectal cancer.
|
J Manag Care Pharm
|
2013
|
0.78
|
|
26
|
Conduct disorder, war zone stress, and war-related posttraumatic stress disorder symptoms in American Indian Vietnam veterans.
|
J Trauma Stress
|
2007
|
0.78
|
|
27
|
An ounce of prevention or a pound of cure? Investing to improve breast cancer outcomes for African American women.
|
J Clin Oncol
|
2004
|
0.76
|
|
28
|
Medical care and bankruptcy: the author replies.
|
Health Aff (Millwood)
|
2013
|
0.75
|
|
29
|
Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
|
Pharmacotherapy
|
2012
|
0.75
|
|
30
|
Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.
|
Future Oncol
|
2015
|
0.75
|